Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review
Abstract
:1. Introduction
1.1. Magnesium Metabolism
1.2. Kidney Function in Relation to Magnesium and Other Implicated Electrolytes
1.3. Kidney Disease and Magnesium
1.4. The Aging Kidney
1.5. Magnesium Alterations in Older Population
2. Materials and Methods
3. Results
Authors | Year | Type of Study | Mean Age or Range and Sex | Population | Date | Measures | Results |
---|---|---|---|---|---|---|---|
Kanbay et. al. [65] | 2012 | Observational cohort study. |
|
|
|
|
|
Wyskida et. al. [66] | 2012 | Prospective, open-label, cross-sectional clinical study. |
|
|
|
|
|
Van Laecke et. al. [67] | 2013 | Retrospective cohort study. |
|
|
|
|
|
Sakaguchi et. al. [58] | 2013 | Observational cohort study |
|
|
|
|
|
Lacson et. al. [68] | 2015 | Observational retrospective cohort study. |
|
|
|
|
|
Rebholz et. al. [69] | 2016 | Prospective cohort study. |
|
|
|
|
|
Ferrè et. al. [70] | 2017 | A multiethnic, population-based, cohort study. |
|
|
|
|
|
Farhadnejad et. al. [71] | 2016 | Prospective population-based cohort study. |
|
|
|
|
|
Azem et. al. [63] | 2020 | Observational cohort study. |
|
|
|
|
|
Galán Carrillo et. al. [64] | 2021 | Retrospective observational cohort study. |
|
|
|
|
|
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Blanchard, A. Metabolismo Normal y Patológico del Magnesio; Elsevier: Amsterdam, The Netherlands, 2007; pp. 1–8. [Google Scholar]
- Glasdam, S.M.; Glasdam, S.; Peters, G.H. The Importance of Magnesium in the Human Body. In Advances in Clinical Chemistry; Elsevier: Amsterdam, The Netherlands, 2016; pp. 169–193. Available online: https://linkinghub.elsevier.com/retrieve/pii/S0065242315000943 (accessed on 1 June 2022).
- Touyz, R.M. Magnesium in clinical medicine. Front. Biosci. 2004, 9, 1278. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, F.; Mohammed, A. Magnesium: The Forgotten Electrolyte—A Review on Hypomagnesemia. Med. Sci. 2019, 7, 56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van de Wal-Visscher, E.R.; Kooman, J.P.; van der Sande, F.M. Magnesium in Chronic Kidney Disease: Should We Care? Blood Purif. 2018, 45, 173–178. [Google Scholar] [CrossRef]
- De Mier, M.P.-R.; Rodelo-Haad, C.; Díaz-Tocados, J.; Muñoz-Castañeda, J.; Rodríguez, M. Magnesium: An old player revisited in the context of CKD-MBD. Clin. Chim. Acta 2019, 501, 53–59. [Google Scholar] [CrossRef] [PubMed]
- Houillier, P. Mechanisms and Regulation of Renal Magnesium Transport. Annu. Rev. Physiol. 2014, 76, 411–430. [Google Scholar] [CrossRef]
- Leehey, D.J. Magnesium Homeostasis in CKD. Adv. Chronic Kidney Dis. 2018, 25, 222–223. [Google Scholar] [CrossRef]
- Cases, A.; Cigarrán-Guldrís, S.; Mas, S.; Gonzalez-Parra, E. Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider. Nutrients 2019, 11, 1263. [Google Scholar] [CrossRef] [Green Version]
- Tang, R.J.; Luan, S. Rhythms of magnesium. Nat. Plants 2020, 6, 742–743. [Google Scholar] [CrossRef]
- Barbagallo, M.; Veronese, N.; Dominguez, L.J. Magnesium in Aging, Health and Diseases. Nutrients 2021, 13, 463. [Google Scholar] [CrossRef]
- Veronese, N.; Demurtas, J.; Pesolillo, G.; Celotto, S.; Barnini, T.; Calusi, G.; Caruso, M.G.; Notarnicola, M.; Reddavide, R.; Stubbs, B.; et al. Magnesium and health outcomes: An umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur. J. Nutr. 2019, 59, 263–272. [Google Scholar] [CrossRef]
- Felsenfeld, A.J.; Levine, B.S.; Rodriguez, M. Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease. Semin. Dial. 2015, 28, 564–577. [Google Scholar] [CrossRef] [PubMed]
- William, J.H.; Richards, K.; Danziger, J. Magnesium and Drugs Commonly Used in Chronic Kidney Disease. Adv. Chronic Kidney Dis. 2018, 25, 267–273. [Google Scholar] [CrossRef] [PubMed]
- Cheungpasitporn, W.; Thongprayoon, C.; Harindhanavudhi, T.; Edmonds, P.J.; Erickson, S.B. Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis. Endocr. Res. 2016, 41, 142–147. [Google Scholar] [CrossRef]
- Van Laecke, S. Hypomagnesemia and hypermagnesemia. Rev. Endocr. Metab. Disord. 2019, 74, 41–47. [Google Scholar] [CrossRef] [PubMed]
- Agus, Z.S. Mechanisms and causes of hypomagnesemia. Curr. Opin. Nephrol. Hypertens. 2016, 25, 301–307. [Google Scholar] [CrossRef] [PubMed]
- Wolf, F.I.; Trapani, V. Cell (patho)physiology of magnesium. Clin. Sci. 2008, 114, 27–35. [Google Scholar] [CrossRef] [Green Version]
- Blaine, J.; Chonchol, M.; Levi, M. Renal Control of Calcium, Phosphate, and Magnesium Homeostasis. Clin. J. Am. Soc. Nephrol. 2015, 10, 1257–1272. [Google Scholar] [CrossRef] [Green Version]
- Oliveira, B.; Cunningham, J.; Walsh, S.B. Magnesium Balance in Chronic and End-Stage Kidney Disease. Adv. Chronic Kidney Dis. 2018, 25, 291–295. [Google Scholar] [CrossRef]
- Dominguez, L.; Veronese, N.; Barbagallo, M. Magnesium and Hypertension in Old Age. Nutrients 2020, 13, 139. [Google Scholar] [CrossRef]
- Allgrove, J. Physiology of calcium, phosphate, magnesium and vitamin D. In Endocrine Development; Allgrove, J., Shaw, N.J., Eds.; S. Karger AG: Basel, Switzerland, 2015; pp. 7–32. Available online: https://www.karger.com/Article/FullText/380990 (accessed on 1 June 2022).
- Vetter, T.; Lohse, M.J. Magnesium and the parathyroid. Curr. Opin. Nephrol. Hypertens. 2002, 11, 403–410. [Google Scholar] [CrossRef]
- Vormann, J. Magnesium and Kidney Health-More on the ‘Forgotten Electrolyte’. Am. J. Nephrol. 2016, 44, 379–380. [Google Scholar] [CrossRef] [PubMed]
- Cunningham, J.; Rodríguez, M.; Messa, P. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin. Kidney J. 2012, 5 (Suppl. S1), i39–i51. [Google Scholar] [CrossRef] [PubMed]
- Kanbay, M.; Goldsmith, D.; Uyar, M.E.; Turgut, F.; Covic, A. Magnesium in Chronic Kidney Disease: Challenges and Opportunities. Blood Purif. 2010, 29, 280–292. [Google Scholar] [CrossRef] [PubMed]
- Spiegel, D.M. Magnesium in Chronic Kidney Disease: Unanswered Questions. Blood Purif. 2011, 31, 172–176. [Google Scholar] [CrossRef] [PubMed]
- Mountokalakis, T.D. Magnesium metabolism in chronic renal failure. Magnes. Res. 1990, 3, 121–127. [Google Scholar]
- Rodríguez-Ortiz, M.E.; Canalejo, A.; Herencia, C.; Martínez-Moreno, J.M.; Peralta-Ramírez, A.; Perez-Martinez, P.; Navarro-González, J.F.; Rodríguez, M.; Peter, M.; Gundlach, K.; et al. Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration. Nephrol. Dial. Transplant. 2013, 29, 282–289. [Google Scholar] [CrossRef] [Green Version]
- Liu, H.; Wang, R. Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis. Medicine 2021, 100, e27486. [Google Scholar] [CrossRef]
- De Francisco, A.L.M.; Rodríguez, M. Magnesium—Its role in CKD. Nefrología 2013, 33, 389–399. [Google Scholar] [CrossRef]
- Xiong, J.; He, T.; Wang, M.; Nie, L.; Zhang, Y.; Wang, Y.; Huang, Y.; Feng, B.; Zhang, J.; Zhao, J. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: A systematic review and meta-analysis. J. Nephrol. 2019, 32, 791–802. [Google Scholar] [CrossRef]
- Huang, J.W.; Famure, O.; Li, Y.; Kim, S.J. Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation. J. Am. Soc. Nephrol. 2015, 27, 1793–1800. [Google Scholar] [CrossRef] [Green Version]
- Augusto, J.-F.; Subra, J.-F.; Duveau, A.; Rakotonjanahary, J.; Dussaussoy, C.; Picquet, J.; Croue, A.; Villemain, F.; Onno, C.; Sayegh, J. Relation Between Pretransplant Magnesemia and the Risk of New Onset Diabetes After Transplantation Within the First Year of Kidney Transplantation. Transplantation 2014, 97, 1155–1160. [Google Scholar] [CrossRef] [PubMed]
- Garg, N.; Weinberg, J.; Ghai, S.; Bradauskaite, G.; Nuhn, M.; Gautam, A.; Kumar, N.; Francis, J.; Chen, J.L.T. Lower magnesium level associated with new-onset diabetes and pre-diabetes after kidney transplantation. J. Nephrol. 2014, 27, 339–344. [Google Scholar] [CrossRef] [PubMed]
- Csiszar, A.; Toth, J.; Peti-Peterdi, J.; Ungvari, Z. The aging kidney: Role of endothelial oxidative stress and inflammation. Acta Physiol. Hung. 2007, 94, 107–115. [Google Scholar] [CrossRef] [PubMed]
- Fang, Y.; Gong, A.Y.; Haller, S.T.; Dworkin, L.D.; Liu, Z.; Gong, R. The ageing kidney: Molecular mechanisms and clinical implications. Ageing Res. Rev. 2020, 63, 101151. [Google Scholar] [CrossRef]
- Grantham, J.J. Solitary Renal Cysts: Worth a Second Look? Am. J. Kidney Dis. 2012, 59, 593–594. [Google Scholar] [CrossRef]
- Al-Said, J.; Brumback, M.A.; Moghazi, S.; Baumgarten, D.A.; O’Neill, W.C. Reduced renal function in patients with simple renal cysts. Kidney Int. 2004, 65, 2303–2308. [Google Scholar] [CrossRef] [Green Version]
- Al-Said, J.; Charles O’Neill, W. Reduced kidney size in patients with simple renal cysts. Kidney Int. 2003, 64, 1059–1064. [Google Scholar] [CrossRef] [Green Version]
- Chin, H.J.; Ro, H.; Lee, H.J.; Na, K.Y.; Chae, D.W. The clinical significances of simple renal cyst: Is it related to hypertension or renal dysfunction? Kidney Int. 2006, 70, 1468–1473. [Google Scholar] [CrossRef] [Green Version]
- Zhou, Y.; Jia, L.; Lu, B.; Bai, L.; Cui, W. Simple renal cyst as an independent risk factor for hypertension. J. Clin. Hypertens. 2022, 24, 898–907. [Google Scholar] [CrossRef]
- Roseman, D.A.; Hwang, S.-J.; Oyama-Manabe, N.; Chuang, M.L.; O’Donnell, C.J.; Manning, W.J.; Fox, C.S. Clinical associations of total kidney volume: The Framingham Heart Study. Nephrol. Dial. Transplant. 2016, 32, 1344–1350. [Google Scholar] [CrossRef] [Green Version]
- Wang, X.; Vrtiska, T.J.; Avula, R.T.; Walters, L.R.; Chakkera, H.A.; Kremers, W.K.; Lerman, L.O.; Rule, A.D. Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int. 2014, 85, 677–685. [Google Scholar] [CrossRef] [Green Version]
- Denic, A.; Glassock, R.J.; Rule, A.D. Structural and Functional Changes With the Aging Kidney. Adv. Chronic Kidney Dis. 2016, 23, 19–28. [Google Scholar] [CrossRef] [Green Version]
- Van der Burgh, A.C.; Rizopoulos, D.; Ikram, M.A.; Hoorn, E.J.; Chaker, L. Determinants of the Evolution of Kidney Function With Age. Kidney Int. Rep. 2021, 6, 3054–3063. [Google Scholar] [CrossRef] [PubMed]
- Piras, D.; Masala, M.; Delitala, A.; Urru, S.A.M.; Curreli, N.; Balaci, L.; Ferreli, L.P.; Loi, F.; Atzeni, A.; Cabiddu, G.; et al. Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population. Nephrol. Dial. Transplant. 2018, 35, 640–647. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- James, M.T.; Hemmelgarn, B.R.; Wiebe, N.; Pannu, N.; Manns, B.J.; Klarenbach, S.W.; Tonelli, M. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: A cohort study. Lancet 2010, 376, 2096–2103. [Google Scholar] [CrossRef] [PubMed]
- Nitta, K.; Okada, K.; Yanai, M.; Takahashi, S. Aging and Chronic Kidney Disease. Kidney Blood Press. Res. 2013, 38, 109–120. [Google Scholar] [CrossRef] [PubMed]
- Curry, J.N.; Yu, A.S.L. Magnesium Handling in the Kidney. Adv. Chronic Kidney Dis. 2018, 25, 236–243. [Google Scholar] [CrossRef]
- Mazzaferro, S.; de Martini, N.; Cannata-Andía, J.; Cozzolino, M.; Messa, P.; Rotondi, S.; Tartaglione, L.; Pasquali, M.; on behalf of the ERA-EDTA CKD-MBD Working Group. Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression. J. Clin. Med. 2021, 10, 958. [Google Scholar] [CrossRef]
- DiNicolantonio, J.J.; O’Keefe, J.H.; Wilson, W. Subclinical magnesium deficiency: A principal driver of cardiovascular disease and a public health crisis. Open Heart 2018, 5, e000668. [Google Scholar] [CrossRef]
- Pickering, G.; Mazur, A.; Trousselard, M.; Bienkowski, P.; Yaltsewa, N.; Amessou, M.; Noah, L.; Pouteau, E. Magnesium Status and Stress: The Vicious Circle Concept Revisited. Nutrients 2020, 12, 3672. [Google Scholar] [CrossRef]
- Uwitonze, A.M.; Razzaque, M.S. Role of Magnesium in Vitamin D Activation and Function. J. Am. Osteopat. Assoc. 2018, 118, 181–189. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Orten-Luiten, A.; Janse, A.; Verspoor, E.; Brouwer-Brolsma, E.; Witkamp, R. Drug use is associated with lower plasma magnesium levels in geriatric outpatients; possible clinical relevance. Clin. Nutr. 2018, 38, 2668–2676. [Google Scholar] [CrossRef]
- Sakaguchi, Y.; Hamano, T.; Isaka, Y. Magnesium and Progression of Chronic Kidney Disease: Benefits Beyond Cardiovascular Protection? Adv. Chronic Kidney Dis. 2018, 25, 274–280. [Google Scholar] [CrossRef] [PubMed]
- Al-Aly, Z.; Maddukuri, G.; Xie, Y. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe. Am. J. Kidney Dis. 2020, 75, 497–507. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sakaguchi, Y.; Fujii, N.; Shoji, T.; Hayashi, T.; Rakugi, H.; Isaka, Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014, 85, 174–181. [Google Scholar] [CrossRef] [Green Version]
- Chung, H.Y.; Cesari, M.; Anton, S.; Marzetti, E.; Giovannini, S.; Seo, A.Y.; Carter, C.; Yu, B.P.; Leeuwenburgh, C. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8, 18–30. [Google Scholar] [CrossRef] [Green Version]
- Sonya, V.; Giuseppina, C.; Carmela Rita, B.; Marco, C.; Giuseppina, C.-R.; Maria Paola, G.; Florinda, L.; Domenico, N.; Domenico, L.; Calogero, C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 2007, 128, 83–91. [Google Scholar]
- Carrero, J.J.; Stenvinkel, P.; Fellström, B.; Qureshi, A.R.; Lamb, K.; Heimbürger, O.; Bárány, P.; Radhakrishnan, K.; Lindholm, B.; Soveri, I.; et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J. Intern. Med. 2008, 263, 302–312. [Google Scholar] [CrossRef] [Green Version]
- Childs, B.G.; Durik, M.; Baker, D.J.; Van Deursen, J.M. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat. Med. 2015, 21, 1424–1435. [Google Scholar] [CrossRef] [Green Version]
- Azem, R.; Daou, R.; Bassil, E.; Anvari, E.M.; Taliercio, J.J.; Arrigain, S.; Schold, J.D.; Vachharajani, T.; Nally, J.; Na khoul, G.N. Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol. 2020, 21, 49. [Google Scholar]
- Carrillo, I.G.; Vega, A.; Goicoechea, M.; Shabaka, A.; Gatius, S.; Abad, S.; López-Gómez, J.M. Impact of Serum Magnesium Levels on Kidney and Cardiovascular Prognosis and Mortality in CKD Patients. J. Ren. Nutr. 2021, 31, 494–502. [Google Scholar] [CrossRef] [PubMed]
- Kanbay, M.; Yilmaz, M.I.; Apetrii, M.; Saglam, M.; Yaman, H.; Unal, H.U.; Gok, M.; Caglar, K.; Oguz, Y.; Yenicesu, M.; et al. Relationship between Serum Magnesium Levels and Cardiovascular Events in Chronic Kidney Disease Patients. Am. J. Nephrol. 2012, 36, 228–237. [Google Scholar] [CrossRef] [PubMed]
- Wyskida, K.; Witkowicz, J.; Chudek, J.; Więcek, A. Daily Magnesium Intake and Hypermagnesemia in Hemodialysis Patients With Chronic Kidney Disease. J. Ren. Nutr. 2012, 22, 19–26. [Google Scholar] [CrossRef] [PubMed]
- Van Laecke, S.; Nagler, E.V.; Verbeke, F.; Van Biesen, W.; Vanholder, R. Hypomagnesemia and the Risk of Death and GFR Decline in Chronic Kidney Disease. Am. J. Med. 2013, 126, 825–831. [Google Scholar] [CrossRef]
- Lacson, E.; Wang, W.; Ma, L.; Passlick-Deetjen, J. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am. J. Kidney Dis. 2015, 66, 1056–1066. [Google Scholar] [CrossRef] [Green Version]
- Rebholz, C.M.; Tin, A.; Liu, Y.; Kuczmarski, M.F.; Evans, M.K.; Zonderman, A.B.; Crews, D.C. Dietary Magnesium and Kidney Function Decline: The Healthy Aging in Neighborhoods of Diversity across the Life Span Study. Am. J. Nephrol. 2016, 44, 381–387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ferre, S.; Li, X.; Adams-Huet, B.; Maalouf, N.M.; Sakhaee, K.; Toto, R.D.; Moe, O.W.; Neyra, J.A. Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study. Nephrol. Dial. Transplant. 2018, 33, 1389–1396. [Google Scholar] [CrossRef]
- Farhadnejad, H.; Asghari, G.; Mirmiran, P.; Yuzbashian, E.; Azizi, F. Micronutrient Intakes and Incidence of Chronic Kidney Disease in Adults: Tehran Lipid and Glucose Study. Nutrients 2016, 8, 217. [Google Scholar] [CrossRef] [PubMed]
- Joosten, M.M.; Gansevoort, R.T.; Bakker, S.J. Low plasma magnesium and risk of developing chronic kidney disease: Results from the PREVEND Study. Kidney Int. 2015, 87, 1262–1263. [Google Scholar] [CrossRef] [Green Version]
- Tin, A.; Grams, M.E.; Maruthur, N.M.; Astor, B.C.; Couper, D.; Mosley, T.H.; Selvin, E.; Coresh, J.; Kao, W.H.L. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int. 2015, 87, 820–827. [Google Scholar] [CrossRef] [Green Version]
- Maier, J.A.M.; Malpuech-Brugère, C.; Zimowska, W.; Rayssiguier, Y.; Mazur, A. Low magnesium promotes endothelial cell dysfunction: Implications for atherosclerosis, inflammation and thrombosis. Biochimica et Biophysica Acta (BBA)-Mol. Basis Dis. 2004, 1689, 13–21. [Google Scholar] [CrossRef] [PubMed]
- Ferrè, S.; Baldoli, E.; Leidi, M.; Maier, J.A. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim. et Biophys. Acta (BBA)-Mol. Basis Dis. 2010, 1802, 952–958. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Li, Y.; Del Gobbo, L.C.; Rosanoff, A.; Wang, J.; Zhang, W.; Song, Y. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension 2016, 68, 324–333. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tótoli, C.; Carvalho, A.B.; Ammirati, A.L.; Draibe, S.A.; Canziani, M.E.F. Associated factors related to chronic kidney disease progression in elderly patients. PLoS ONE 2019, 14, e0219956. [Google Scholar] [CrossRef] [PubMed]
- Sakaguchi, Y.; Shoji, T.; Hayashi, T.; Suzuki, A.; Shimizu, M.; Mitsumoto, K.; Kawabata, H.; Niihata, K.; Okada, N.; Isaka, Y.; et al. Hypomagnesemia in Type 2 Diabetic Nephropathy. Diabetes Care 2012, 35, 1591–1597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kyriazis, J.; Kalogeropoulou, K.; Bilirakis, L.; Smirnioudis, N.; Pikounis, V.; Stamatiadis, D.; Liolia, E. Dialysate magnesium level and blood pressure. Kidney Int. 2004, 66, 1221–1231. [Google Scholar] [CrossRef] [Green Version]
- Ishimura, E.; Okuno, S.; Yamakawa, T.; Inaba, M.; Nishizawa, Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes. Res. 2007, 20, 237–244. [Google Scholar]
- Salem, S.; Bruck, H.; Bahlmann, F.H.; Peter, M.; Passlick-Deetjen, J.; Kretschmer, A.; Steppan, S.; Volsek, M.; Kribben, A.; Nierhaus, M.; et al. Relationship between Magnesium and Clinical Biomarkers on Inhibition of Vascular Calcification. Am. J. Nephrol. 2011, 35, 31–39. [Google Scholar] [CrossRef]
- Turgut, F.; Kanbay, M.; Metin, M.R.; Uz, E.; Akcay, A.; Covic, A. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int. Urol. Nephrol. 2008, 40, 1075–1082. [Google Scholar] [CrossRef]
- Kircelli, F.; Peter, M.E.; Ok, E.S.; Celenk, F.G.; Yilmaz, M.; Steppan, S.; Asci, G.; Passlick-Deetjen, J. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol. Dial. Transplant. 2011, 27, 514–521. [Google Scholar] [CrossRef]
- Schulze, M.B. Fiber and Magnesium Intake and Incidence of Type 2 Diabetes: A Prospective Study and Meta-analysis. Arch. Intern. Med. 2007, 167, 956. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rodríguez-Morán, M.; Guerrero-Romero, F. Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects. Diabetes Care 2003, 26, 1147–1152. [Google Scholar] [CrossRef] [Green Version]
- Guerrero-Romero, F.; Rodríguez-Morán, M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: Double-blind, randomized clinical trial. Eur. J. Clin. Investig. 2011, 41, 405–410. [Google Scholar] [CrossRef] [PubMed]
- Sakaguchi, Y. The emerging role of magnesium in CKD. Clin. Exp. Nephrol. 2022, 26, 379–384. [Google Scholar] [CrossRef]
- Lee, H.; Oh, Y.J.; Kim, M.; Kim, H.; Lee, J.P.; Kim, S.; Oh, K.-H.; Chin, H.J.; Joo, K.W.; Lim, C.S.; et al. The association of moderate renal dysfunction with impaired preference-based health-related quality of life: 3rdKorean national health and nutritional examination survey. BMC Nephrol. 2012, 13, 19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maggio, M.; Ceda, G.P.; Lauretani, F.; Cattabiani, C.; Avantaggiato, E.; Morganti, S.; Ablondi, F.; Bandinelli, S.; Dominguez, L.J.; Barbagallo, M.; et al. Magnesium and anabolic hormones in older men: Magnesium and anabolic status in older men. Int. J. Androl. 2011, 34, e594–e600. [Google Scholar] [CrossRef] [Green Version]
- Kurita, N.; Horie, S.; Yamazaki, S.; Otani, K.; Sekiguchi, M.; Onishi, Y.; Takegami, M.; Ono, R.; Konno, S.-I.; Kikuchi, S.-I.; et al. Low Testosterone Levels and Reduced Kidney Function in Japanese Adult Men: The Locomotive Syndrome and Health Outcome in Aizu Cohort Study. J. Am. Med. Dir. Assoc. 2016, 17, 371.e1–371.e6. [Google Scholar] [CrossRef] [Green Version]
- Ford, E.S.; Mokdad, A.H. Dietary Magnesium Intake in a National Sample of U.S. Adults. J. Nutr. 2003, 133, 2879–2882. [Google Scholar] [CrossRef] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Macías Ruiz, M.d.C.; Cuenca Bermejo, L.; Veronese, N.; Fernández Villalba, E.; González Cuello, A.M.; Kublickiene, K.; Raparelli, V.; Norris, C.M.; Kautzky-Willer, A.; Pilote, L.; et al. Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review. Nutrients 2023, 15, 1710. https://doi.org/10.3390/nu15071710
Macías Ruiz MdC, Cuenca Bermejo L, Veronese N, Fernández Villalba E, González Cuello AM, Kublickiene K, Raparelli V, Norris CM, Kautzky-Willer A, Pilote L, et al. Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review. Nutrients. 2023; 15(7):1710. https://doi.org/10.3390/nu15071710
Chicago/Turabian StyleMacías Ruiz, María del Carmen, Lorena Cuenca Bermejo, Nicola Veronese, Emiliano Fernández Villalba, Ana María González Cuello, Karolina Kublickiene, Valeria Raparelli, Colleen M. Norris, Alexandra Kautzky-Willer, Louise Pilote, and et al. 2023. "Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review" Nutrients 15, no. 7: 1710. https://doi.org/10.3390/nu15071710